Liver–Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework
- 1Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of China
- 2Department of Hepatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of China
- 3Department of Geriatrics, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of China
Abstract
Liver and lung metastases in pancreatic ductal adenocarcinoma (PDAC) differ in timing, molecular features, and clinical course. We propose that these differences emerge through five interacting processes: pre-existing predisposition, anatomical delivery, premetastatic conditioning, organ-specific selection, and adaptive colonization. This narrative review integrates clinical observations with genetically engineered mouse models (GEMMs), lineage tracing, and functional perturbation to explain liver–lung divergence. The framework organizes organ preference around the states available before dissemination, the cells delivered to each organ, and their subsequent survival and growth. It connects each process to an experimental readout, allowing recurrent-site associations and causal mechanisms to inform a common biological question. GEMM studies reveal early dissemination, heterogeneous metastatic competence, polyclonal seeding, and changes in tumor-cell and stromal organization across metastatic lesion sizes. Genetic manipulation of epithelial adhesion and tissue-specific signaling further identifies distinct requirements for hepatic and pulmonary colonization. Complementary transplantation experiments demonstrate organ-dependent responses to SMAD4 restoration and PCSK9 perturbation. Together, these findings support a probabilistic interpretation in which the same tumor-cell program can confer different advantages according to the target organ and stage of progression. Clinical recurrence patterns provide a complementary view of this biology, with isolated pulmonary disease often associated with a more indolent course. By linking evidence to the process it measures, the framework identifies opportunities to reduce dissemination, disrupt organ conditioning, or inhibit established metastatic growth and guides the design of prospective studies of organ-specific risk and treatment response.
Related
- Borderline resectable pancreatic ductal adenocarcinoma: a narrative review
- Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma
- Prognostic and Spatial Organization of Tertiary Lymphoid Structures in Pancreatic Ductal Adenocarcinoma
- Identification of miR-615-5p/ID1 axis crucial in the pathogenesis of pancreatic ductal adenocarcinoma (PDAC)
- Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features
BibTeX
@article{cong2026liverlung,
title = {{Liver–Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework}},
author = {Baodan Cong and Kunfei Deng and Yu Du and Kaidi Sun},
journal = {Cancer Management and Research},
year = {2026},
month = oct,
doi = {10.2147/cmar.s644548},
url = {https://doi.org/10.2147/cmar.s644548},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Liver–Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework
AU - Baodan Cong
AU - Kunfei Deng
AU - Yu Du
AU - Kaidi Sun
PY - 2026
DA - 2026/10/30
JO - Cancer Management and Research
DO - 10.2147/cmar.s644548
UR - https://doi.org/10.2147/cmar.s644548
AB - Liver and lung metastases in pancreatic ductal adenocarcinoma (PDAC) differ in timing, molecular features, and clinical course. We propose that these differences emerge through five interacting processes: pre-existing predisposition, anatomical delivery, premetastatic conditioning, organ-specific selection, and adaptive colonization. This narrative review integrates clinical observations with genetically engineered mouse models (GEMMs), lineage tracing, and functional perturbation to explain liver–lung divergence. The framework organizes organ preference around the states available before dissemination, the cells delivered to each organ, and their subsequent survival and growth. It connects each process to an experimental readout, allowing recurrent-site associations and causal mechanisms to inform a common biological question. GEMM studies reveal early dissemination, heterogeneous metastatic competence, polyclonal seeding, and changes in tumor-cell and stromal organization across metastatic lesion sizes. Genetic manipulation of epithelial adhesion and tissue-specific signaling further identifies distinct requirements for hepatic and pulmonary colonization. Complementary transplantation experiments demonstrate organ-dependent responses to SMAD4 restoration and PCSK9 perturbation. Together, these findings support a probabilistic interpretation in which the same tumor-cell program can confer different advantages according to the target organ and stage of progression. Clinical recurrence patterns provide a complementary view of this biology, with isolated pulmonary disease often associated with a more indolent course. By linking evidence to the process it measures, the framework identifies opportunities to reduce dissemination, disrupt organ conditioning, or inhibit established metastatic growth and guides the design of prospective studies of organ-specific risk and treatment response.
SN - 1179-1322
ER -